Sherrington Robin, EVP, Strategy & Innovation at Xenon Pharmaceuticals Inc. (XENE), sold 14,759 shares at $46.30 ($683K) on 2024-03-07, disclosed to the SEC on 2024-03-08.
Open-market sale of $683k XENE by EVP, Strategy & Innovation. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.96 | 215 | $10K | 1.4% |
| 2 | $45.96 | 1,289 | $59K | 8.7% |
| 3 | $46.15 | 1,019 | $47K | 6.9% |
| 4 | $46.30 | 6,118 | $283K | 41.5% |
| 5 | $46.30 | 6,118 | $283K | 41.5% |
| Total | $46.25 avg | 14,759 |
| $683K |
| 100% |
| Filing → |
| XENE | SELL | 2021-06-01 | $228K | — | Filing → |